It is difficult to speak with scientific restraint of the contributions of Edgar Allen to mankind. It is perhaps enough to say that here in New Haven the important school of anatomists, which knew his influence, thrives with vigor, and that his work has profoundly influenced biology universally, as will be apparent later in this lecture.
Sexual maturity, in addition to conferring certain biological rights and privileges, entails an increased susceptibility to neoplasms. If any proof is needed, consider cancer of the breast which is exdusively a disease of adult life where in man more than 99 per cent of the cases occur in females."3 The relationship of tumors to the male sex is well recognized also. Gastric cancer is slightly commoner in the male13 19 ; among white males the death rate from cancer of the buccal cavity was seven times that for white females,13 while cancers of the lung, skin, and urinary bladder occur more than twice as frequently in men as in women.
Maleness does not differ from femaleness in hormones alone; the occupation and habits of man enter into the causation of his diseases. There is, however, a well-recognized androgenic hormonal component operative in certain neoplasms. This will be discussed at this time.
Beginning with the extraction of an estrogenic agent from the ovaries of the hog 'by Allen and Doisy2 in 1923 numerous studies have been made of the sex hormones and many androgenic substances as well as estrogens have been isolated in a crystalline state; not only has their chemical constitution 'been determined, but partial or complete synthesis of most of them has been achieved. This work represents one of the greatest triumphs of science.
Androgen is a stimulant of growth causing certain areas to increase in cell mass, the response representing the result of a complex interplay of chemical agents acting on end-organs specifically reactive to these forces. The responsive areas are most diversified and growth is strikingly observed, inter alia, in the integument and its appendages, the musde, larynx, and the accessory sex structures. Areal hyperplasia is always of interest in the neoplastic prdblem, since the cancerous process is likewise a selective growth of specific cellular areas.
The cells in which androgen causes growth are 'by definition the secondary sexual characteristics of the constitutional male but these agents also induce growth in the uterus1' and mammary ducts of the female,4' 59, 65 these structures being responsive to both androgen and estrogen. The effects of androgen on the uterus are particularly marked in dogs (Figs. I and 2 ). The name androgen is, therefore, terminologically inexact but despite its lack of precision it is convenient to retain, for want of a better, in studies of function.
The important feature of activity of the sex hormones seems to be the action on tissues of specific atomic groups which profoundly modify cellular functions, and the study of intramolecular spatial relationships is beginning to be rewarding in this field. Schueler58 has postulated that a given structure may be estrogenic if it consists of a rather large, rigid, and inert molecular structure with two active hydrogen bond-forming groups, such as phenolic hydroxyl, located at the optimum distance of 8.55 A units from each other. However, if the active groups are at a distance of approximately 9 to 10 A and are somewhat weaker in hydrogen bond-forming character, for example secondary alcoholic hydroxyl groups, the substance should have androgenic activity. The dosage of the most active androgen to produce characteristic effects is considerably larger than the quantity of estrogen needed to produce estrus and this may be related to the weaker hydrogen bond-forming power in the androgen.
Lacking as yet better characterization, androgen for technical purposes is anything which causes specific growth of carefully defined areas, such as the comb of the capon or tall epithelium in the prostate gland of mammals, regions which are not stimulated by most 3. In a castrate dog appropriate doses of estrogen largely vitiate27 the effect of injected androgen on the prostate. Diethylstilbestrol, 0.1 mg. daily, stops the secretion of prostatic fluid in a normal dog.
4. The primary effect of estrogen in abolishing prostatic section is through androgen deprivation because of pituitary inhibition; the injection of equine gonadotrophin simultaneously with effective amounts of estrogen25 will restore the failing prostatic output after estrogen alone has caused prostatic atrophy.
The prostate gland of dogs on casual examination seems to be a simple structure, being composed of a single mass of tissue composed of cells of uniform type. However, closer observation reveals25 that the canine prostate is composed of two distinct functional units, the dorsal and ventral segments. In the normal adult the epithelium of both segments consists of tall columnar secretory cells. The differentiation into segments is apparent only after estrogen therapy. These two areas react differently to estrogen; the epithelium of the dorsal segment is transformed to squamous cells by a threshold dose of estrogen; the cells of the ventral segment never become so modified.
This multiplicity of structure of the prostate is not confined to the dog. It has been known for some time that the anterior lobes of the prostate of the rat and guinea-pig,867 68 and of the monkey"6 differ from the remaining lobes in that they alone possess the power of coagulating the secretion of the seminal vesicle of these species. Canine prostatic fluid does not induce coagulation. Nevertheless, the evidence for structural duality in the dog is dear cut.
The influence of androgen on tumors The androgenic hormones bear three relationships to neoplastic growth, namely, inhibition, stimulation, and no effect. Lack of effect, being always of secondary scientific interest, will not be considered further here. The modifications of the activity of tumors will be presented in the following eight cases where androgen certainly exerts an influence
In these four instances androgen inhibits the development of neoplasms:
Case 1, Mammary cancer in the mouse. Nathanson and Andervont52 found that the incidence of breast cancer in mice of the strain C3H which had borne a litter was 100 per cent in the controls while it was 30 per cent in similar mice injected with testosterone propionate, 0.5 mg., 3 times weekly. This reduced rate of incidence has been confirmed for this32 and other mouse strains23 37 42 with high incidence of breast cancer.
Case 2, Mammtary adenofibrona in the rat. Heiman and Krehbid24 found that implantation of this tumor was followed by effective takes in 33 per cent of intact males, in 66 per cent of females, and in 80 per cent of castrate males. It was observed also that estrogen more than doubled the incidence of successful implants,2' while testosterone propionate22 in male and female rats reduced the number of takes to about one quarter of the con-trols. Mohs'' 4 o _bserved that androgen eliminated the epithelial elements of adenofibroma although it did not inhibit the growth of the entire tumor.
Case 3, Uterine and abdominal fibroids in the guinea-pig. Lipschiutz and his pupils40' 4 observed that the action of estrogen in producing these fibromyomata was blocked by testosterone, there resulting either no tumor or only a little fibrosis or tumoral seed. Case 4, Lymphoid tumors in mice and fowl. In most strains of mice with a high leukemia incidence there is a greater rate of involvement in the female than in males; in the fowl, Marine and Rosen43' 4 had not observed lymphomatosis occurring in a bird with spontaneous comb growth. Now, Gardner'7 had discovered that estrogen was a factor in producing lymphoid tumor of mice, and Gardner, Dougherty, and Williams'8 conducted an elaborate experiment revealing androgenic inhibition of the development of leukemia; in 822 control mice the incidence of leukemia was 1.34 per cent, while in 1799 mice injected with estrogen the incidence was 11.9 per cent. These observers found that the administration of testosterone propionate with estrogen in 378 mice reduced the incidence to 2.3 per cent. The inducing action of estrogen was clearly inhibited by androgen.
In his strain of mice Murphy50 observed a high incidence of leukemia in intact females and castrte males and females, while the development of lymphoid tumors was apprecialbly lower in in-tact males and in castrate females injected with androgen.
In Furth's laboratory45 gonadectomy in the female reduced the incidence of leukemia in mice from 74 to 45 per cent, while in the male it had essentially no effect. In this single case androgen causes some neoplastic regression: Case 5, Cancer of the human female breast. Ulrich64 administered testosterone acetate to a woman with mammary cancer and observed regression of edema of the axilla which was -believed to have been caused by metastasis. Loeser42 treated three women having metastatic mammary cancer with implantation of large amounts of testosterone. While two of the cases were stated to have had temporary improvement in general health and there was regression of the tumor in one, the progress of the cancer was stated to have been unaltered. Fels"6 treated three women with androgen; in one case there was some regression of lymph nodes which were the site of metastasis and in the others there was decrease of pain and some improvement of general health. Adair and Herrmann' administered androgen in large doses and concluded that in certain cases it may effect a beneficial influence on patients with mammary cancer. In their series of eleven patients four exhibited a favorable response to testosterone propionate, 2 to 4 gm. administered within two to three months; in one of the women there was regression of the primary tumor as well as the soft part metastasis, while in three cases there was an increased calcification of osteolytic lesions with a concomitant disappearance of pain. Farrow androgen caused an exacerbation of adlvanced prostatic cancer28 and conversely that anti-androgenic treatment frequently induced a clinical remission3' which often was pronounced in degree. Estrogen was thus the first agent of known chemical constitution to ameliorate carcinomatosis in man and the only substance known at that time which, when taken by mouth, influenced cancer beneficially. The method of proof is sometimes of more interest than what is proven; the first cobjective demonstration of the effects of hormones on prostatic carcinoma was derived from a study of the phosphatases of the blood which often reflected the improvement from the decrease of androgenic activity. The benefit of androgen control, however, was not limited to the enzymes of serum and often both the primary lesion and the metastasis underwent more or less regression.
The remissions, although frequently of some magnitude, were followed by a relapse before 5 years had elapsed in 80 per cent of the first series of cases treated by orchiectomy; however four of these original 20 patients who previously had extensive states of metastatic malignant disease have no evidence of neoplastic activity on clinical or chemical examination after periods varying from six to seven and one-half years,26 the patients still being under observation.
In some of the cases of relapse after remission, the recrudescence of disease is due to the elaboration of a functionally significant amount of androgen26 in an extragonadal depot-the suprarenal gland. This is believed to be essentially the only source of androgen besides the testis in the human male, because excision of the adrenals and gonads in man30 eliminates the excreton in the urine of materials capable of effecting comb growth and also the urinary 1 7-ketosteroids fall to very low levels.
In certain cases of prostatic cancer the tumor may be or may become independent of androgen. This evidence is based on adrenalectomy in a man who suffered a clinical relapse after the remission of cancerous activity which followed orchiectomy. Life was supported for four months after suprarenalectomy30 by adrenal substitutive therapy; yet in this case the cancer followed an unfavorable course. In this relation bear in mind that in the normal male while castration is followed by a marked decrease in prostatic size it does not cause the epithelial cells of the prostate to disappear; they merely shrink and remain functionally quiescent.
Case 8, Cancer of the human male breast. Farrow and Adair"4 administered testosterone propionate to a man with metastatic mammary cancer and observed an increase in the number and extent of the metastases, while bilateral orchiectomy was followed by clinical improvement. In the series of Treves63 there was partial regression in 2 of 6 men with extensive breast cancer after excision of the testes.
Uncertain influence of androgen in neoplasms:
In the following three cases, uncertainty arises because the results are unconfirmed or in controversy.
Case 9, Hepatomas. In mice of strain C3H Burns and Schenken9 observed hepatomas in 27 per cent of breeding males, 7 per cent of non-breeding males, and in no breeding females. They57 also injected other mice of this strain with testosterone propionate and with estrogens; androgen was reported to reduce the incidence of hepatomas very much while estrogen increased it in the males.
Cantarow et al."0 injected esters of testosterone or estradiol in rats of the Sherman strain which were also fed 2 acetamino-fluorene. In the small series of animals reported, neoplasms were encountered in 69 per cent of the estrogen series, 80 per cent of the androgen group, and 29 per cent of the controls. The authors thought that the increased incidence may be related to the role of the liver in the intermediary metabolism and excretion of the steroids.
Case 10, Brown-Pearce epithelioma. Murlin, Kochakian, Spurr, and Harvey49 inoculated this tumor into the testes of rabbits, injecting some of them with various steroids. Androgenic extracts from urine and testosterone propionate inhibited the growth and metastasis of the tumors.
Case 11, Transplantable tumors. Murphy and Sturm"' and later Pribram54' 5 found that castration in male mice increased the immunity to several types of transplantable tumors. Stewart6" and Woglom69 observedl no effect of castration on the induction of tumors in mice of C3H strain by 1: 2: 5: 6 dibenzathracene.
Discussion
The action of androgen on tumors is either to cause inhibition of the development of a neoplasm or to cause exacer'bation of its growth. Only in the single case of cancer of the breast in women does androgen result in regression of the neoplasm.
It now remains to consider how far present knowledge of cell function can explain the effects of androgen on malignancy.
The physiological neutralization of estrogen by androgen is a quantitative competition of these steroids for control of the cell which precisely resembles the metabolite inhibitors which have been studied in a number of cases such as p-am-ino benzoic acid and the sulfon-amide type of drugs. 58 The evidence for this similarity in the case of androgen-estrogen antagonism is derived from their structural resemblance and also from the fact that when these hormones are present together in vivo the ratio between them determines which of the variously acting steroids will have dominance; quantitatively inhibition requires much greater amounts of one of the agents (sulfonamide, androgen) than of its antagonist (PABA, estrogen). To this metabolite antagonism is ascribed the inhibition of the development of tumors (cases 1-4) since the availability of the estrogen is blocked by the androgen.
Not enough data are available to discuss the furthering influences of androgen on cancer of the breast in men or ovarian cancer in the mouse wvithout an unreasonable amount of speculation.
In cancer of the breast of women one finds an extremely complicated tumor in what, from an endocrine standpoint, is an extraordinarily complex tissue. The mammary gland is stimulated by the steroids, estrogen and progesterone; by the protein hormones, prolactin and mammotrophin; and to a less extent by androgen and desoxycorticosterone. c Clinical improvement has been reported, and convincingly, in breast cancer of human females from such widely divergent treatment as ovarian excision and the administration of androgen or estrogen. Beatson This confused state of affairs makes it difficult to evaluate ameliorating effects on breast cancer of such divergent treatments as androgen or estrogen or the removal of ovarian hormones by ovariectomy. Although some regression seems to have resulted from all of these measures, the impression is obtained that the endocrine treatment of mammary cancer commonly is neither so great nor so prolonged as occurs in the chemotherapy of other tumors such as prostatic cancer, and that the percentage of reduction of man-pain hours is less. More work is needed. We need to know the percentage of improvement and the duration of the remissions in larger series. We need to know the activity of the human pituitary in breast cancer-knowledge which is now totally lacking, because the only common physiological action of androgen and estrogen is hypophyseal depression. Above all, we need to know how the sex hormones influence enzyme systems of normal and of malignant cells.
Fortunately the prostate gland is simpler than the breast endocrinologically, being affected directly by only two hormones, androgen and estrogen. The stimulation of prostatic cancer by androgen and the regression of the tumor whatever its locus in the body by androgen control is in exact line with the physiological effect of this hormone on the mammalian prostate. Many of these prostatic cancers are as highly dependent on androgen as is the normal prostatic epithelium, while other neoplasms of this gland achieve autonomy and thus become beyond control by the physiologic means available at present.
Conclusion
Androgen has a profound effect on many neoplasms, ranging from inhibition of the development of tumors to a stimulation of cancerous growth. Many of the effects are explainable by present knowledge of the physiological effects of androgen on cells. The anti-androgenic therapy of cancer of the prostate demonstrates that a chemical change in the internal environment of the host may bring about rapid and long-continued regression of a malignant epithelial process.
